Skip to main content

Keay Nakae

Stock Analyst at Chardan Capital

Total Price Targets
6
Stocks Covered
5
Sectors
Healthcare
Most Recent
Mar 2, 2026

Notable Calls (Last 12 Months)

Most Bullish

  • DYN+135.3%
    Dyne Therapeutics, Inc.
    $38.00 targetMar 2, 2026
  • MNPR+16.9%
    Monopar Therapeutics Inc.
    $85.00 targetSep 25, 2025
  • STOK+13.3%
    Stoke Therapeutics, Inc.
    $35.00 targetJan 5, 2026

Most Bearish

  • ALNY+5.7%
    Alnylam Pharmaceuticals, Inc.
    $475.00 targetOct 31, 2025
  • STOK+13.3%
    Stoke Therapeutics, Inc.
    $35.00 targetJan 5, 2026
  • MNPR+16.9%
    Monopar Therapeutics Inc.
    $85.00 targetSep 25, 2025

Stocks Covered by Keay Nakae

SymbolCompanyLatest TargetCurrent PriceUpside# TargetsLast Updated
DYNDyne Therapeutics, Inc.$38.00$17.50+117.1%2Mar 2, 2026
STOKStoke Therapeutics, Inc.$35.00$33.22+5.4%1Jan 5, 2026
ALNYAlnylam Pharmaceuticals, Inc.$475.00$297.62+59.6%1Oct 31, 2025
MNPRMonopar Therapeutics Inc.$85.00$53.02+60.3%1Sep 25, 2025
ARWRArrowhead Pharmaceuticals, Inc.$29.97$74.82-59.9%1Nov 27, 2024

Recent Activity

  • Mar 2, 2026— Set$38.00price target onDYN(Dyne Therapeutics, Inc.)
  • Jan 5, 2026— Set$35.00price target onSTOK(Stoke Therapeutics, Inc.)
  • Oct 31, 2025— Set$475.00price target onALNY(Alnylam Pharmaceuticals, Inc.)
  • Sep 25, 2025— Set$85.00price target onMNPR(Monopar Therapeutics Inc.)
  • Nov 27, 2024— Set$29.97price target onARWR(Arrowhead Pharmaceuticals, Inc.)
  • May 21, 2024— Set$42.00price target onDYN(Dyne Therapeutics, Inc.)

Frequently Asked Questions

Who is Keay Nakae?

Keay Nakae is a stock analyst at Chardan Capital covering 5 stocks primarily in Healthcare. They have issued 6 price targets since May 21, 2024.

What stocks does Keay Nakae cover?

Keay Nakae currently covers 5 stocks, including DYN, STOK, ALNY, MNPR, ARWR.

What is Keay Nakae's latest price target?

Keay Nakae's most recent price target was $38.00 on DYN (Dyne Therapeutics, Inc.), set on Mar 2, 2026.

What is Keay Nakae's highest price target?

Keay Nakae's highest issued price target is $475.00 on ALNY, set on Oct 31, 2025.

Coverage based on publicly published price targets. Not investment advice.